Search Within

Billel Gasmi

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. Biostatistics Service (9)
  2. Department of Medicine (9)
  3. Epidemiology and Biostatistics (9)
  4. GSK Faculty (8)
  5. Melanoma and Immunotherapeutics Service (8)
  6. Solid Tumor Oncology Division (8)

More Groups

People
  1. Jedd Wolchok (8)
  2. Taha Merghoub (8)
  3. Katherine Panageas (6)
  4. Cailian Liu (5)
  5. Sadna Budhu (5)
  6. Daniel Hirschhorn Cymerman (4)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (3)
  5. 2017 (1)
  6. 2015 (1)
Publications
  1. Cancer Research (2)
  2. Journal for ImmunoTherapy of Cancer (2)
  3. Blood (1)
  4. Cancer Cell (1)
  5. Journal of Immunology (1)
  6. Nature (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Biomed Central Ltd (2)
  3. American Society of Hematology (1)
  4. Cell Press (1)
  5. Impact Journals (1)
  6. Nature Publishing Group (1)

More Publishers

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Overcoming immune resistance with rationally designed combination immunotherapy
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Sirard, C.; Qi, J.; Liu, C.; Li, Y.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Zhong, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
    Journal Article

    Moral, J. A.; Leung, J.; Rojas, L. A.; Ruan, J.; Zhao, J.; Sethna, Z.; Ramnarain, A.; Gasmi, B.; Gururajan, M.; Redmond, D.; more...
    Nature (2020)

    Fulltext@MSK | Save
  • Tissue-specific innate lymphoid cells are novel targets for pancreatic cancer immunotherapy
    Meeting Abstract

    Leung, J.; Rojas, L. A.; Ruan, J.; Zhao, J.; Gasmi, B.; Sethna, Z.; Ramnarain, A.; Bhanot, U.; Askan, G.; Gururajan, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Presence of PD-1 expressing T cells predicts for inferior overall survival in newly diagnosed multiple myeloma
    Meeting Abstract

    Gasmi, B.; Smith, E. L.; Dogan, A.; Hsu, M.; Devlin, S.; Pichardo, J. D.; Chung, D. J.; Koehne, G.; Korde, N. S.; Landau, H. J.; more...
    Blood (2015)

    Fulltext@MSK | Save